激活蛋白 1 (AP-1) 不是单一的蛋白质,而是一个统称,指由 Jun (c-Jun、JunB、JunD)、Fos (c-Fos、FosB、Fra-1、Fra-2) ATF (激活转录因子、ATF-2、ATF-3/LRF1、ATF-4、ATF-5、ATF-6B、ATF-7、BATF、BATF-2、BATF-3、JDP2) 或 MAF (c-MAF、MafA、MafB、MafF、MafG、MafK 和 Nrl) 亚基组成的二聚体转录因子,这些亚基与一个共同的 DNA 位点(AP-1 结合位点)结合。AP-1 参与多种细胞和生理功能。它被认为是无数细胞外信号的主要整合者,使细胞能够适应环境的变化。AP-1 还与各种严重疾病有关。这些包括移植排斥、纤维化、器官损伤和各种炎症病理,如类风湿性关节炎、哮喘和牛皮癣。此外,癌症无疑是涉及 AP-1 的最有据可查的病理,其活性经常失调,并导致细胞转化、肿瘤进展、侵袭性和对治疗的抵抗力。
Activator Protein 1 (AP-1) is not a single protein, but a collective term referring to dimeric transcription factors composed of Jun (c-Jun, JunB, JunD), Fos (c-Fos, FosB, Fra-1, Fra-2) ATF (activating transcription factor, ATF-2, ATF-3/LRF1, ATF-4, ATF-5, ATF-6B, ATF-7, BATF, BATF-2, BATF-3, JDP2) or MAF (c-MAF, MafA, MafB, MafF, MafG, MafK and Nrl) subunits that bind to a common DNA site, the AP-1-binding site. AP-1 is involved in a plethora of cellular and physiological functions. It is acknowledged as a master integrator of a myriad of extracellular signals allowing cells to adapt to changes in their environment. AP-1 has also been implicated in various severe diseases. These include transplant rejection, fibrosis, organ injury and a variety of inflammatory pathologies such as rheumatoid arthritis, asthma and psoriasis. In addition, cancer is undoubtedly the most documented pathology involving AP-1 where its activity is often dysregulated and contributes to cell transformation, tumor progression, aggressiveness and resistance to treatments.
FOSL1 degrader 1 是一种 DC50 为 2.3 μM 的 FOSL1 PROTAC 降解剂,可诱导 FOSL1 的蛋白酶体降解,清除头颈部鳞状细胞癌中的癌症干细胞并抑制其肿瘤发生,可用于头颈部鳞状细胞癌的相关研究(粉色:FOSL1 配体 (MS-T19433);蓝色:Cereblon 配体 (MS-Q68284);黑色:连接子 (MS-O89375))。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号